Are there new therapies on the horizon for PD? Only a few of the compounds studied in the lab will make it to the shelves of your pharmacy. But in this "pipeline," there are promising new therapies being tested.
Find out more by joining PDF and Dr. Sethi for a one-hour PD ExpertBriefing.
- To understand limitations of current medical therapies for Parkinson's disease.
- To review the improved formulations of existing therapies that are in development.
- To describe novel compounds in the pipeline for the treatment of Parkinson's disease.
Dr. Sethi has been actively involved in numerous clinical trials on Parkinson’s disease and restless legs syndrome. His numerous works have been published in leading peer-reviewed journals, including Archives of Neurology, Movement Disorders and Annals of Neurology.
Dr. Sethi is an Associate Editor of Movement Disorders and has served as an editorial reviewer for the New England Journal of Medicine, Lancet Neurology, Journal of the Neurological Sciences and over a dozen other journals. He is a founding member and Vice President of the Tremor Research Group; a fellow of the American Academy of Neurology (AAN) and the Royal College of Physicians of London; and a member of the Parkinson Study Group, American Neurological Association, and World Health Organization International Advisory Board for the revision for ICD-10 diseases of the nervous system. Dr. Sethi has participated on a number of committees for AAN and theMovement Disorder Society (MDS), including as a member of the MDS International Executive Committee in 2002 and MDS Board of Directors from 2001 to 2005, and as Treasurer of AAN Foundation. Dr. Sethi is a frequently invited lecturer and has held visiting professorships at nearly 20 universities.
Dr. Sethi earned his medical degree from the Christian Medical College in Ludhiana, India. He pursued his medical training in neurology at the Post Graduate Institute of Medical Education and Research in Chandigarh, India, followed by a research fellowship in neurology at the Charing Cross Group of Hospitals and Medical School in London, United Kingdom. He then served as a registrar in neurology at the Welsh National School of Medicine at Morriston Hospital, United Kingdom, and later a neurology resident at GHSU.